Trials / Completed
CompletedNCT03406208
Resiliency Training for Adults With Neurofibromatosis Via Live Videoconferencing
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 228 (actual)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aims of this study are to compare the effect and durability of two stress and symptom management programs tailored for patients with neurofibromatosis on quality of life and psychosocial functioning.
Detailed description
The aims of this study are to compare the effect of two stress and symptom management programs tailored for patients with neurofibromatosis on quality of life and psychosocial functioning. We will also examine the degree to which treatment-dependent improvements in quality of life are mediated by improvements in depression, anxiety, distress, mindfulness, gratitude, social support, empathy, optimism, coping, pain intensity and pain interference.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Stress and Symptom Management Program 1 | The Stress and Symptom Management Program 1 (SMP1) introduces and reinforces stress and symptom management skills. The program consists of 8 weekly sessions (90 minutes each), delivered through live videoconferencing. |
| BEHAVIORAL | Stress and Symptom Management Program 2 | The Stress and Symptom Management Program 2 (SMP2) introduces and reinforces stress and symptom management skills. The program consists of 8 weekly sessions (90 minutes each), delivered through live videoconferencing. |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2022-02-28
- Completion
- 2022-02-28
- First posted
- 2018-01-23
- Last updated
- 2025-12-24
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03406208. Inclusion in this directory is not an endorsement.